Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney

Meer Fakhry1, Mandeep S Sidhu2, Sripal Bangalore3

  • 1Department of Medicine, University of South Carolina School of Medicine, Columbia, SC 29208, USA.

Insights

Coronary artery disease (CAD) in chronic kidney disease (CKD) patients presents uniquely, often silently. Key features include increased coronary artery calcification (CAC) and microcirculatory dysfunction, impacting heart function.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a major cause of death in chronic kidney disease (CKD) patients.
  • CAD in CKD exhibits distinct features compared to the general population, including reduced symptom presentation and therapeutic response.
  • Unique pathological characteristics of CAD in CKD include heightened coronary artery calcification (CAC) and impaired coronary microcirculatory function.

Purpose of the Study:

  • To investigate the unique characteristics of coronary artery disease (CAD) in patients with chronic kidney disease (CKD).
  • To explore the roles of coronary artery calcification (CAC) and coronary microcirculatory dysfunction in CAD among CKD patients.
  • To understand the combined impact of CAC and microcirculatory dysfunction on myocardial function and silent myocardial infarction in CKD.

Main Methods:

  • Review of existing literature on CAD in CKD patients.
  • Analysis of pathophysiological pathways contributing to CAC in CKD.
  • Examination of the pathophysiology of coronary microcirculatory dysfunction in CKD.
  • Assessment of the relationship between CAC and microcirculatory dysfunction.

Main Results:

  • Patients with CKD exhibit increased calcific density of atherosclerotic plaques and vessels (CAC).
  • Coronary microcirculatory dysfunction is prevalent in CKD patients with CAD.
  • The interplay between CAC and microcirculatory dysfunction contributes to more severe impacts on myocardial function.
  • These factors may explain the higher incidence of silent myocardial infarction in CKD.

Conclusions:

  • CAD in CKD possesses unique features, notably increased CAC and microcirculatory dysfunction.
  • Further research is essential to elucidate the pathophysiology and therapeutic strategies for CAD in CKD.
  • Understanding these unique aspects is crucial for managing cardiovascular risk in CKD patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
427
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
436
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
198
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
203
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
679